LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 79 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,164,000 | +1.6% | 505,941 | 0.0% | 0.46% | -21.0% |
| Q2 2016 | $4,098,000 | +61.4% | 505,941 | +1.2% | 0.58% | +52.1% |
| Q1 2016 | $2,539,000 | -34.2% | 499,815 | 0.0% | 0.38% | -17.3% |
| Q4 2015 | $3,859,000 | +34.0% | 499,815 | 0.0% | 0.46% | +0.4% |
| Q3 2015 | $2,879,000 | -37.2% | 499,815 | 0.0% | 0.46% | -24.5% |
| Q2 2015 | $4,583,000 | -10.9% | 499,815 | +17.7% | 0.61% | -23.4% |
| Q1 2015 | $5,145,000 | – | 424,815 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,229,916 | $26,582,000 | 9.98% |
| FRAZIER MANAGEMENT LLC | 2,087,281 | $17,178,000 | 8.43% |
| Avoro Capital Advisors LLC | 4,257,347 | $35,038,000 | 6.15% |
| Broadfin Capital, LLC | 2,638,259 | $21,713,000 | 1.95% |
| Perceptive Advisors | 3,567,553 | $29,360,000 | 1.90% |
| Opaleye Management Inc. | 280,000 | $2,304,000 | 1.21% |
| Ghost Tree Capital, LLC | 825,000 | $6,790,000 | 1.10% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,349,500,000 | 0.85% |
| QVT Financial LP | 1,751,509 | $14,335,000 | 0.54% |
| Cormorant Asset Management, LP | 505,941 | $4,164,000 | 0.46% |